Lysophosphatidylcholine inhibits lung cancer cell proliferation by regulating fatty acid metabolism enzyme long‐chain acyl‐coenzyme A synthase 5
Abstract Lung cancer is a widespread malignancy with a high death rate and disorder of lipid metabolism. Lysophosphatidylcholine (lysoPC) has anti‐tumour effects, although the underlying mechanism is not entirely known. The purpose of this study aims at defining changes in lysoPC in lung cancer pati...
Main Authors: | Linlin Zhang, Xuanqi Liu, Yifei Liu, Furong Yan, Yiming Zeng, Yuanlin Song, Hao Fang, Dongli Song, Xiangdong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.1180 |
Similar Items
-
Plasma Lipidomics Analysis Reveals the Potential Role of Lysophosphatidylcholines in Abdominal Aortic Aneurysm Progression and Formation
by: Ting Xie, et al.
Published: (2023-06-01) -
Lipidomic analysis of serum samples from migraine patients
by: Caixia Ren, et al.
Published: (2018-02-01) -
Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein
by: Hiroyuki Itabe, et al.
Published: (2021-06-01) -
Impact of Treatment with RUTF on Plasma Lipid Profiles of Severely Malnourished Pakistani Children
by: Engy Shokry, et al.
Published: (2020-07-01) -
Metabolomic Analysis Reveals the Mechanisms of Hepatotoxicity Induced by Aflatoxin M1 and Ochratoxin A
by: Ya-Nan Gao, et al.
Published: (2022-02-01)